Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
3.
Br J Anaesth ; 120(6): 1176-1186, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29793584

RESUMO

BACKGROUND: Whether supplemental intraoperative oxygen reduces surgical site infections remains unclear. Recent recommendations from the World Health Organization and Center for Disease Control to routinely use high inspired oxygen concentrations to reduce infection risk have been widely criticized. We therefore performed a meta-analysis to evaluate the influence of inspired oxygen on infection risk, including a recent large trial. METHODS: A systematic literature search was performed. Primary analysis included all eligible trials. Sensitivity analyses distinguished studies of colorectal and non-colorectal surgeries, and excluded studies with high risk of bias. Another post-hoc sensitivity analysis excluded studies from one author that appear questionable. RESULTS: The primary analysis included 26 trials (N=14,710). The RR [95%CI] for wound infection was 0.81 [0.70, 0.94] in the high vs. low inspired oxygen groups. The effect remained significant in colorectal patients (N=10,469), 0.79 [0.66, 0.96], but not in other patients (N=4,241), 0.86 [0.69, 1.09]. When restricting the analysis to studies with low risk of bias, either by strict inclusion criteria (N=5,047) or by researchers' judgment (N=12,547), no significant benefit remained: 0.84 [0.67, 1.06] and 0.89 [0.76, 1.05], respectively. CONCLUSIONS: When considering all available data, intraoperative hyperoxia reduced wound infection incidence. However, no significant benefit remained when analysis was restricted to objective- or investigator-identified low-bias studies, although those analyses were not as well-powered. Meta-analysis of the most reliable studies does not suggest that supplemental oxygen substantively reduces wound infection risk, but more research is needed to fully answer this question.


Assuntos
Cuidados Intraoperatórios/métodos , Oxigenoterapia/métodos , Infecção da Ferida Cirúrgica/prevenção & controle , Viés , Humanos
4.
Br J Anaesth ; 120(5): 1110-1116, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29661388

RESUMO

BACKGROUND: The role of obesity as a risk factor for difficult intubation remains controversial. We primarily assessed the association between body mass index (BMI) and difficult tracheal intubation. METHODS: We analysed electronic records of more than 67 000 adults having elective non-cardiac surgery requiring tracheal intubation at the Cleveland Clinic between 2011 and 2015. The association between BMI and difficult intubation, defined as more than one intubation attempt, was assessed using multivariable logistic regression adjusting for pre-specified confounders. RESULTS: Amongst 40 183 patients with BMI <30 kg m-2 and 27 519 with BMI ≥30 kg m-2, 9% required more than one intubation attempt. Increasing BMI up to 30 kg m-2 was significantly associated with increased odds of more than one intubation attempt [odds ratio (OR): 1.03; 97.5% confidence interval (CI): 1.02, 1.04] per unit increase in BMI, P < 0.001. However, the odds of difficult intubation remained unchanged once BMI exceeded 30 kg m-2 (P = 0.08). The results were similar when analysis was restricted to patients without history of airway abnormalities in whom intubation was attempted using a standard direct laryngoscope (OR: 1.03; 99.4% CI: 1.01, 1.04) per kg m-2 increase in BMI <30 kg m-2). CONCLUSIONS: Increasing BMI was associated with increasing odds of difficult intubation in the lean range. At higher BMI, the odds of difficult intubation remain elevated, but there is no additional increase in odds with further increase in BMI. Obese patients were thus harder to intubate than lean ones, but difficult intubation was no more likely in morbidly obese patients than in those who were only slightly obese.


Assuntos
Índice de Massa Corporal , Intubação Intratraqueal/estatística & dados numéricos , Obesidade/complicações , Adulto , Idoso , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sistema de Registros , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença , Resultado do Tratamento
5.
Br J Anaesth ; 119(4): 803-811, 2017 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-29121296

RESUMO

BACKGROUND: The anti-inflammatory effects of statins have been suggested to relieve postoperative pain. This retrospective study tested the association between the perioperative routine use of statins in therapeutic doses, and opioid requirements and pain scores, after hip replacement surgery. METHODS: With IRB approval, data was obtained for adult patients who had elective hip replacement surgery under spinal anaesthesia at Cleveland Clinic between 2005 and 2015. Patients were compared using a joint hypothesis framework. We used the inverse probability of treatment weighting method to control for observed confounding factors (a total of 26). RESULTS: We included 611 statin users and 780 non-statin users. Pain score during the initial 72 h after surgery was 0.07 higher (95% CI: -0.02, 0.17) in statin users (noninferiority test in both directions P<0.001). The estimated ratio of geometric means in the cumulative i.v. morphine equivalent opioid consumption was 1.01 (95% CI: 0.93, 1.10) for statin vs non-statin users (noninferiority test P=0.001 in the hypothesized direction and<0.001 in the other direction) during the initial 72 h after surgery. The statin and non-statin patients were deemed equivalent on postoperative opioid consumption and pain score. CONCLUSIONS: This is the first large retrospective clinical study that investigates the effects of statin use on postoperative pain and opioid consumption. We observed no difference between statin users and non-users during the initial 72 h after hip surgery. Our findings do not support the routine use of statins as part of an analgesic regimen.


Assuntos
Analgésicos Opioides/uso terapêutico , Raquianestesia/métodos , Artroplastia de Quadril , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Dor Pós-Operatória/tratamento farmacológico , Assistência Perioperatória/métodos , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
8.
Anaesthesist ; 65(7): 514-20, 2016 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-27245923

RESUMO

BACKGROUND: The Ventrain® emergency ventilation device allows active inspiration and expiration through transtracheal catheters or the lumen of an airway exchange catheter. This single-use handheld device is manually operated and driven by an external pressurized oxygen source. The Ventrain® may be used to ventilate patients with a complete or pending upper airway obstruction reducing the risk of barotrauma due to the possibility of active expiration. However tidal volumes (V T) applied and withdrawn with the Ventrain® can only be controlled by visual inspection of chest movements; V T monitoring is not provided. Excessive inspiratory volumes or air trapping due to insufficient expiration may remain clinically undetected until pulmonary trauma and/or cardio-respiratory deterioration occur. Active expiration itself carries the risk of overwhelming lung deflation with the formation of atelectasis. Thus, an inspiratory and expiratory tidal volume monitor is urgently required. The aim of this study was to evaluate efficacy and precision of the Florian respiratory function monitor (RFM) to monitor in- and expiratory V T administered by the Ventrain® emergency ventilation device through a small cannula to the ASL 5000 test lung (ASL). METHODS: In an in-vitro setting the RFM was used with its neonatal flow sensor to monitor inspiratory and expiratory V T applied by the Ventrain® emergency ventilation device through a 2 mm internal diameter (ID) transtracheal catheter to the ASL. Driving flows of 6, 9, 12 and 15 l min(-1) were chosen to vary tidal volumes at a constant respiratory rate of 15 min(-1) and an I:E ratio of 1:1. Experiments were repeated five times with two flow sensors. An initial set-up calibration run was performed to calculate a bias correction factor for inspiratory and expiratory V T measured by the RFM. This bias correction factor was used to simulate a correction of the in the RFM programmed linearization table. In a second, identical setting the experiments were repeated five times with two flow sensors. V T measured by the adjusted RFM were compared with those obtained from the ASL 5000 in this second run and the percentage differences were calculated. Bland Altman analysis was used to investigate the agreement of inspiratory or expiratory VT measured by both methods (ASL and RFM). Calculation of the mean of differences between both methods is given as bias and the 95 % agreement interval as precision. RESULTS: Tidal volumes measured by the ASL ranged from 140 to 675 ml. The percentage correction factor was 16.27 % (2.60 %) during inspiration for V T ranged from 0 to 700 ml and 11.51 % (2.56 %) during expiration for V T of 0 to 225 ml, 7.41 % (2.94 %) for VT 226 to 325 ml and 5.35 % (3.57 %) for TV e > 325 ml. Inspiratory and expiratory tidal volumes measured by the adjusted RFM demonstrated a percentage deviation (mean [SD]) of 2.59 % (1.86 %) during inspiration and 1.66 % (1.14 %) during expiration when compared with the ASL 5000. Bias (precision) of the Bland Altman plot for the adjusted RFM is 2.05 ml (23.20) during inspiration and 4.62 ml (10.40) for expiration. CONCLUSION: The tested respiratory function monitor using hot-wire anemometer technology has the potential to monitor tidal volumes applied by the Ventrain®. With the software thus adapted, the RFM measures precise inspiratory and expiratory tidal volumes within common technical tolerance. This could help perform adequate patient ventilation with Ventrain® and reduce the potential risk of patient trauma.


Assuntos
Serviços Médicos de Emergência/métodos , Monitorização Fisiológica/instrumentação , Monitorização Fisiológica/métodos , Respiração Artificial/métodos , Volume de Ventilação Pulmonar , Ventiladores Mecânicos , Adulto , Humanos , Recém-Nascido , Segurança do Paciente , Reprodutibilidade dos Testes , Espirometria
9.
Acta Anaesthesiol Scand ; 60(2): 241-9, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26612252

RESUMO

BACKGROUND: The Ventrain(®) (Dolphys Medical, Eindhoven, The Netherlands) is a disposable handheld ventilation device allowing active inspiration and expiration through a transtracheal catheter. This study investigated Ventrain(®) 's performance when used with different clinical oxygen sources in an in vitro set-up. METHODS: Three anesthesia oxygen sources (wall-mounted flowmeter, respirator oxygen outlet port, and anesthesia ventilator circuit) were used at gas flow rates of 6, 9, 12, and 15 l/min. First, the sources' driving pressures (DP), the insufflation pressure (IP), and the flow at the catheter tip were measured using a gas flow analyzer. Tidal volumes (VT) delivered by the Ventrain(®) were assessed by the ASL5000 test lung (respiratory rate: 15 min(-1), I:E = 1:1, compliance: 100 ml/cmH2O, resistance: 3.06 cmH2O/l/s). RESULTS: VT ranged from 82 to 483 ml for inspiration and 82 to 419 ml for expiration. Measured IP, flow, and VT were less dependent on the set gas flow rate but more on the source's DP. With rising DP the IP, the flow at the catheter tip and consequently VT increased. At an approximate target I:E ratio of 1:1, the ratio of inspiratory to expiratory VT increased with higher DP and gas flow rates. CONCLUSION: The oxygen sources resulted in clinically different IP, flows, and VT delivered by the Ventrain(®) at given gas flow rates. This needs to be considered in a clinical emergency situation. Integrating an adjustable pressure valve into Ventrain(®) to allow regulation of the lowest necessary IP would make its use safer.


Assuntos
Equipamentos Descartáveis , Oxigênio/administração & dosagem , Ventiladores Mecânicos , Humanos
10.
Anaesthesist ; 64(7): 513-9, 2015 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-26174747

RESUMO

INTRODUCTION: Securing the airway with a tracheal tube is essential in emergency situations, in the intensive care setting as well as during anesthesia for surgery and other interventions. Current methods of airway assessment are poor screening tests for predicting difficult direct laryngoscopy due to a generally low positive predictive value; therefore, successful endotracheal intubation requires a high level of expertise, regular training and practice and sometimes additional tools. Currently, several video laryngoscopes (VL) with different designs are commercially available and have been investigated in a wide variety of settings. To our knowledge there is no prospective study evaluating and comparing performance among these three groups of VL; therefore, the aim of this study was to compare performance of five VL and conventional direct laryngoscopy in an intubation manikin model, both in a normal and simulated difficult intubation setting. METHODS: In this study 10 residents, 12 senior staff physicians and 5 anesthesia nurses, all experienced in conventional direct laryngoscopy and inexperienced with VL underwent theoretical and hands-on training with all VL lasting 60 min. Afterwards participants performed intubation with all 5 VL and conventional direct laryngoscopy in a randomized sequence using an intubation manikin with normal intubation settings. Thereafter participants performed intubation in a simulated difficult intubation setting using the same intubation manikin with a neck collar to immobilize the cervical spine. In this study, the C-MAC(®) with Macintosh blade size 3, GlideScope(®) size 3, McGrath(®) series 5, King Vision(®) and Airtraq(®) size 2 were used. Time to intubation served as primary outcome and time to glottis visualization, number of intubation attempts, success rate and subjective evaluation of difficulty served as secondary outcomes. RESULTS: In the normal intubation setting, time to intubation ranged from 16.0 s (conventional direct laryngoscopy) to 34.3 s (McGrath). GlideScope and conventional direct laryngoscopy were successful in 100 % followed by C-MAC (96.7 %), Airtraq (88.9 %), King Vision (77.8 %) and McGrath VL (44.4 %). In the simulated difficult intubation setting, time to intubation ranged between 20.3 s (Airtraq) and 26.7 s (McGrath). Success rate with C-MAC was 100 %, followed by GlideScope (96.7 %), Airtraq (85.2 %), conventional direct laryngoscopy (85.2 %), King Vision (81.5 %) and McGrath VL (70.4 %). CONCLUSION: In the manikin with normal intubation setting, conventional direct laryngoscopy using a Macintosh blade was convincing and superior to any VL used in this study. During simulated difficult intubation, a blade with video transmission, such as C-MAC and the GlideScope were superior compared to conventional direct laryngoscopy and any other VL tested.


Assuntos
Manuseio das Vias Aéreas/instrumentação , Anestesiologia/educação , Intubação Intratraqueal/instrumentação , Laringoscópios , Laringoscopia/instrumentação , Manequins , Manuseio das Vias Aéreas/métodos , Competência Clínica , Desenho de Equipamento , Glote/anatomia & histologia , Humanos , Internato e Residência , Intubação Intratraqueal/métodos , Laringoscopia/métodos , Enfermeiros Anestesistas , Estudos Prospectivos , Resultado do Tratamento , Gravação em Vídeo
11.
Br J Anaesth ; 109(5): 790-6, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22831890

RESUMO

BACKGROUND: Arterial catheterization is painful and is associated with patient stress and anxiety. Analgesia is usually provided by subcutaneous injection of local anaesthetic. An alternative is topical anaesthesia, such as Rapydan which is a novel topical anaesthetic patch containing 70 mg each of lidocaine and tetracaine. We therefore tested the hypothesis that Rapydan patch analgesia is non-inferior to subcutaneous local anaesthetic. METHODS: Ninety patients undergoing elective major cardiac surgery were included in this prospective, double-blind clinical trial. Patients were randomly assigned to receive either a lidocaine/tetracaine patch, followed by subcutaneous injection 0.5 ml of normal saline solution, or placebo patch with subsequent subcutaneous injection of 0.5 ml of lidocaine 1%. Pain during arterial catheterization using 100-mm-long visual analogue scale (VAS) was the primary outcome. Other outcomes were pain during anaesthetic/saline injection and plasma tetracaine concentrations. RESULTS: VAS pain scores during arterial puncture were comparable in both groups and Rapydan was non-inferior to subcutaneous lidocaine. Pain scores at the time of subcutaneous injection were significantly lower (better) in patients assigned to the lidocaine/tetracaine patch than to lidocaine (P=0.001). Plasma tetracaine concentrations never exceeded the detection limit of 25 ng ml(-1) at any time in any patient. CONCLUSIONS: Both the lidocaine/tetracaine patch and subcutaneous injection of lidocaine provided comparable pain control during arterial catheter insertion. Subcutaneous lidocaine caused discomfort during injection, whereas the lidocaine/tetracaine patch required placement 20 min before the procedure. Given adequate time, the patch provided better overall analgesia by obviating the need for subcutaneous infiltration.


Assuntos
Anestésicos Locais/administração & dosagem , Cateterismo Venoso Central/efeitos adversos , Lidocaína/administração & dosagem , Dor/prevenção & controle , Tetracaína/administração & dosagem , Adesivo Transdérmico , Administração Cutânea , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anestesia Local/métodos , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor/etiologia , Estudos Prospectivos , Adulto Jovem
12.
Br J Anaesth ; 106(6): 896-902, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21493621

RESUMO

BACKGROUND: In several clinical situations, lung separation and single-lung ventilation (SLV) is essential. In these cases, the double-lumen tube (DLT) is the most widely used device. Bronchial blocker such as Univent or Arndt Blocker serves as an alternative. The EZ-Blocker(®) (EZ; AnaesthetIQ B.V., Rotterdam, The Netherlands) is a new device promising to exceed clinical performance of DLT. The aim of this study was to assess the clinical performance of EZ in comparison with conventional left-sided DLT. METHODS: Forty adult patients undergoing elective thoracic surgery requiring thoracotomy and SLV were included in this study. The patients were randomly assigned to one of two groups: EZ (combined with conventional 7.5 or 8.5 mm single-lumen tube) or DLT (37 or 39 Fr left-sided DLT). Time for intubation procedure and time to verification of the correct position of EZ or DLT using fibreoptic bronchoscopy (FOB) were recorded. After surgery, a thoracic surgeon rated the quality of collapse of the lung (1-3 on a three-level scale). RESULTS: Time for intubation using DLT 85.5 (54.8) s was significantly faster (P<0.001) than using EZ 192 (89.7) s, whereas time for bronchoscopy was not significantly different (P=0.556). Conditions of surgery were rated equally [DLT 1.3 (0.6) vs EZ 1.4 (0.6), P=0.681]. CONCLUSIONS: Although time for intubation was longer with the EZ, the device proved to be an efficient and easy-to-use device. The EZ is a valuable alternative device to conventional DLT. Verification of the correct position of the EZ by FOB seems to be obligatory. This study was registered at http://www.clinicaltrials.gov (identifier: NCT01171560).


Assuntos
Respiração Artificial/instrumentação , Procedimentos Cirúrgicos Torácicos/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Broncoscopia , Desenho de Equipamento , Feminino , Rouquidão/etiologia , Humanos , Intubação Intratraqueal/efeitos adversos , Intubação Intratraqueal/instrumentação , Masculino , Pessoa de Meia-Idade , Faringite/etiologia , Respiração Artificial/efeitos adversos , Respiração Artificial/métodos , Toracotomia/métodos , Adulto Jovem
13.
Nature ; 222(5197): 983-4, 1969 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-5789327
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...